Ultrafast bone scintigraphy scan for detecting bone metastasis using a CZT whole-body gamma camera

PurposeTo evaluate the feasibility of short whole-body bone scan acquisition times using a novel gamma camera with cadmium-zinc-telluride (CZT) semiconductor detectors.MethodsWe retrospectively enrolled 78 consecutive patients with prostate cancer who underwent bone scintigraphy using a whole-body gamma camera with CZT detectors. After acquisition of list-mode data with 180 s per bed position, anterior and posterior whole-body images were reconstructed using the first 5%, 10%, 25%, 50%, 75% and 100% of the list-mode data. Two experienced nuclear medicine physicians interpreted the images, and interrater agreement and the diagnostic value of the images were determined. Quantitative artificial neural network (ANN) values, bone scan indexes (BSI) and hotspot numbers (HsN) were also calculated by automated diagnostic software.ResultsExcellent interrater reliabilities of the visual assessments were obtained for the 100%, 75%, 50%, and 25% images (κ = 0.88, 0.88, 0.88 and 0.88, respectively). The 5% images also showed high diagnostic value (sensitivity 0.94, specificity 0.84 and accuracy 0.86). Intraclass correlation coefficients (ICC) between the 100% images and the reduced acquisition time images were evaluated in quantitative analyses, and excellent correlations were observed for ANN value in the 75% images (ICC 0.77), for BSI in all the reduced acquisition time images (75%, 50%, 25%, 10% and 5%; ICC 0.99, 0.99, 0.99, 0.96 and 0.75, respectively), and for HsN in the 75%, 50%, 25% and 10% images (ICC 0.99, 0.99, 0.98 and 0.90, respectively).ConclusionWhole-body gamma cameras with CZT detectors have the potential to reduce image acquisition times and the dose of radioisotope injected for bone scans.

[1]  S. Larson,et al.  A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition , 2016, The Journal of Nuclear Medicine.

[2]  Tohru Shiga,et al.  Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: a Japanese multi-center database project , 2013, EJNMMI Research.

[3]  M. Oyama,et al.  Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer , 2017, European Journal of Hybrid Imaging.

[4]  S. Larson,et al.  Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  V. Treyer,et al.  Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  K. Miwa,et al.  Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting , 2015, Annals of Nuclear Medicine.

[7]  S M Larson,et al.  A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  M. Koyama,et al.  Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups , 2017, Annals of Nuclear Medicine.

[9]  M. Lomsky,et al.  Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer , 2016, The Journal of Nuclear Medicine.

[10]  J. Mortensen,et al.  223Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity , 2017, The Journal of Nuclear Medicine.

[11]  I. Matsunari,et al.  Quantification of osteoblastic activity in epiphyseal growth plates by quantitative bone SPECT/CT , 2018, Skeletal Radiology.

[12]  Mattias Ohlsson,et al.  A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. , 2012, European urology.

[13]  C. Logothetis,et al.  Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.

[14]  Feng Wang,et al.  68Ga-DOTA-NGR as a novel molecular probe targeting APN/CD13 for tumor angiogenesis imaging , 2013 .

[15]  Valerie Treyer,et al.  Nuclear Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride Detector Technique: Optimized Protocol for Scan Time Reduction , 2010, Journal of Nuclear Medicine.

[16]  S. Baba,et al.  Influence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System, BONENAVI, on Bone Scintigraphy Images , 2017, Asia Oceania journal of nuclear medicine & biology.

[17]  Hubert Cochet,et al.  Absolute Quantification of Left Ventricular Global and Regional Function at Nuclear MPI Using Ultrafast CZT SPECT : Initial Validation Versus Cardiac MR , 2013 .

[18]  M. Morris,et al.  Current perspectives on bone metastases in castrate-resistant prostate cancer , 2018, Cancer and Metastasis Reviews.

[19]  Stoffer Reiffers,et al.  Impact of a new ultrafast CZT SPECT camera for myocardial perfusion imaging: fewer equivocal results and lower radiation dose , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  Markus Krönke,et al.  Exploring New Multimodal Quantitative Imaging Indices for the Assessment of Osseous Tumor Burden in Prostate Cancer Using 68Ga-PSMA PET/CT , 2017, The Journal of Nuclear Medicine.

[21]  P. Pretorius,et al.  SPECT/CT: an update on technological developments and clinical applications. , 2018, The British journal of radiology.